OPK

MKT CAP:$1B

Opko Health Inc

Market Cap

$1B

Healthcare·Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Diagnostics·🇺🇸·NASDAQ

Stock Price

$1.20-$0.07 (-5.51%)

Jul 15, 2026

52W High $1.5852W Low $1.10

Company Details

OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops ...

Leadership

Phillip Frost M.D., Ph.D.

Chairman of the Board & CEO

Jane H. Hsiao M.B.A., Ph.D.

Vice Chairman of the Board & Chief Technical Officer

Elias Adam Zerhouni M.D.

President & Vice Chairman of the Board

Adam E. Logal

Senior VP, CFO, Chief Accounting Officer & Treasurer

Steven D. Rubin Esq., J.D.

Executive VP of Administration & Director

Akhtar Ashfaq FACP, FASN, M.D.

Senior Vice President of Clinical Research & Development and Medical Affairs - Opko Renal

Gary J. Nabel M.D., Ph.D.

Chief Innovation Officer & Director

Giovanni Abbadessa M.D., Ph.D.

Chief Medical Officer of ModeX

John R. Mascola M.D.

Chief Scientific Officer of ModeX

Charles W. Bishop Ph.D.

Chief Executive Officer of OPKO Renal

IPO Date

Nov 2, 1995

Website

www.opko.com

Key Metrics TTM

Revenue

$1.3B

-28.4% YoY

Net Income

$18M

EPS (Diluted)

Free Cash Flow

-$174M

Revenue / Share

$1.82

Gross Margin

36.1%

Operating Margin

5.1%

Net Margin

1.4%

FCF Margin

-13.7%

P/S

0.8x

P/E

57.3x

Revenue & Profitability

Operating Cash Flow

CapEx Spend

Stock-Based Compensation

OpEx Breakdown

Revenue by Geography

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee